New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 1, 2020 - Par launched AB-rated generic versions of BioMarin’s Kuvan (sapropterin) tablet and oral packets.
Download PDF
Return to publications
